Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension.

Pascual JM, Rodilla E, Gonzalez C, Pérez-Hoyos S, Redon J.

Hypertension. 2005 Jun;45(6):1125-30. Epub 2005 May 16.

PMID:
15897369
2.

Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension.

Redon J, Rovira E, Miralles A, Julve R, Pascual JM.

Hypertension. 2002 Mar 1;39(3):794-8.

PMID:
11897766
3.

Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study.

Pascual JM, Rodilla E, Miralles A, Gonzalez C, Redon J.

J Hypertens. 2006 Nov;24(11):2277-84.

PMID:
17053551
4.

Prognostic value of microalbuminuria during antihypertensive treatment in essential hypertension.

Pascual JM, Rodilla E, Costa JA, Garcia-Escrich M, Gonzalez C, Redon J.

Hypertension. 2014 Dec;64(6):1228-34. doi: 10.1161/HYPERTENSIONAHA.114.04273. Epub 2014 Sep 22.

PMID:
25245391
5.

Risk factors for development of microalbuminuria in diabetic and nondiabetic normoalbuminuric hypertensives with high or very high cardiovascular risk - a twelve-month follow-up study.

Cotter J, Oliveira P, Cunha P, Polónia J.

Nephron Clin Pract. 2009;113(1):c8-15. doi: 10.1159/000228070. Epub 2009 Jul 10.

PMID:
19590230
6.

High-normal diastolic blood pressure is a risk for development of microalbuminuria in the general population: the Watari study.

Konno S, Hozawa A, Miura Y, Ito S, Munakata M.

J Hypertens. 2013 Apr;31(4):798-804. doi: 10.1097/HJH.0b013e32835e2146.

PMID:
23340164
7.

Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST.

Palatini P, Mormino P, Dorigatti F, Santonastaso M, Mos L, De Toni R, Winnicki M, Dal Follo M, Biasion T, Garavelli G, Pessina AC; HARVEST Study Group.

Kidney Int. 2006 Aug;70(3):578-84. Epub 2006 Jun 21.

8.

Polymorphisms of the angiotensinogen gene and the outcome of microalbuminuria in essential hypertension: a 3-year follow-up study.

Marin P, Julve R, Chaves FJ, Giner V, Pascual JM, Armengod ME, Redon J.

J Hum Hypertens. 2004 Jan;18(1):25-31.

PMID:
14688807
9.

Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension.

Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES.

Atherosclerosis. 2011 May;216(1):199-204. doi: 10.1016/j.atherosclerosis.2011.01.026. Epub 2011 Jan 21.

10.

Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.

Kato T, Horio T, Tomiyama M, Kamide K, Nakamura S, Yoshihara F, Nakata H, Nakahama H, Kawano Y.

Nephrol Dial Transplant. 2007 Mar;22(3):911-6. Epub 2006 Dec 1.

PMID:
17142262
11.

Development, progression, and regression of microalbuminuria in Japanese patients with type 2 diabetes under tight glycemic and blood pressure control: the Kashiwa study.

Yamada T, Komatsu M, Komiya I, Miyahara Y, Shima Y, Matsuzaki M, Ishikawa Y, Mita R, Fujiwara M, Furusato N, Nishi K, Aizawa T.

Diabetes Care. 2005 Nov;28(11):2733-8.

PMID:
16249548
13.

Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability.

Redon J, Liao Y, Lozano JV, Miralles A, Pascual JM, Cooper RS.

J Hypertens. 1994 Aug;12(8):947-53.

PMID:
7814854
15.

Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment.

Rodilla E, Pascual JM, Costa JA, Martin J, Gonzalez C, Redon J.

J Hypertens. 2013 Aug;31(8):1683-91. doi: 10.1097/HJH.0b013e328361461e.

PMID:
23835910
16.

Hyperinsulinemia as a determinant of microalbuminuria in essential hypertension.

Redon J, Miralles A, Pascual JM, Baldó E, Robles RG, Carmena R.

J Hypertens. 1997 Jan;15(1):79-86.

PMID:
9050974
17.

Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.

Dominguez LJ, Barbagallo M, Kattah W, Garcia D, Sowers JR.

Am J Hypertens. 1995 Aug;8(8):808-14.

PMID:
7576397
18.

Pulse pressure and isolated systolic hypertension: association with microalbuminuria. The GUBBIO Study Collaborative Research Group.

Cirillo M, Stellato D, Laurenzi M, Panarelli W, Zanchetti A, De Santo NG.

Kidney Int. 2000 Sep;58(3):1211-8.

19.

Influence of the I/D polymorphism of the angiotensin-converting enzyme gene on the outcome of microalbuminuria in essential hypertension.

Redon J, Chaves FJ, Liao Y, Pascual JM, Rovira E, Armengod ME, Cooper RS.

Hypertension. 2000 Jan;35(1 Pt 2):490-5.

PMID:
10642347
20.

Urinary albumin excretion at follow-up predicts cardiovascular outcomes in subjects with resistant hypertension.

Oliveras A, Armario P, Sierra C, Arroyo JA, Hernández-del-Rey R, Vazquez S, Larrousse M, Sans L, Roca-Cusachs A, de la Sierra A.

Am J Hypertens. 2013 Sep;26(9):1148-54. doi: 10.1093/ajh/hpt074. Epub 2013 Jun 8.

PMID:
23747954

Supplemental Content

Support Center